# Blue Biofuels, Inc.: financial statements, quarterly

BIOF · OTC · CIK 1549145 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/biof.md) · [Financials](/companies/biof/financials.md) · [Filings](/companies/biof/filings.md) · [Insiders](/companies/biof/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/biof/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $k | [294](/filings/0001493152-24-043492.md) | [109 d](/filings/0001493152-25-010854.md) | [608](/filings/0001641172-25-007701.md) | [291](/filings/0001641172-25-021604.md) | [411](/filings/0001493152-25-019032.md) | [1,020 d](/filings/0001493152-26-011555.md) | [351](/filings/0001493152-26-021038.md) | [471](/filings/0001493152-26-036714.md) | [486](/filings/0001493152-25-019032.md) | [997 d](/filings/0001493152-26-011555.md) | [385](/filings/0001493152-26-021038.md) | [431](/filings/0001493152-26-036714.md) |
| Operating income | $k | [(513)](/filings/0001493152-24-043492.md) | [(505) d](/filings/0001493152-25-010854.md) | [(904)](/filings/0001641172-25-007701.md) | [(541)](/filings/0001641172-25-021604.md) | [(648)](/filings/0001493152-25-019032.md) | [(1,964) d](/filings/0001493152-26-011555.md) | [(689)](/filings/0001493152-26-021038.md) | [(903)](/filings/0001493152-26-036714.md) | [(836)](/filings/0001493152-25-019032.md) | [(1,287) d](/filings/0001493152-26-011555.md) | [(659)](/filings/0001493152-26-021038.md) | [(731)](/filings/0001493152-26-036714.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(332)](/filings/0001493152-24-043492.md) | [(505) d](/filings/0001493152-25-010854.md) | [(947)](/filings/0001493152-25-019032.md) | [(549)](/filings/0001493152-25-019032.md) | [1,866](/filings/0001493152-25-019032.md) | [(1,789) d](/filings/0001493152-26-011555.md) | [(244)](/filings/0001493152-26-036714.md) | [(921)](/filings/0001493152-26-036714.md) | [(423)](/filings/0001493152-25-019032.md) | [(1,287) d](/filings/0001493152-26-011555.md) | [(664)](/filings/0001493152-26-036714.md) | [(751)](/filings/0001493152-26-036714.md) |
| Diluted EPS | $ per share | [(0.00)](/filings/0001493152-24-043492.md) | not reported | [(0.00)](/filings/0001641172-25-007701.md) | [(0.00)](/filings/0001641172-25-021604.md) | [0.01](/filings/0001493152-25-019032.md) | not reported | [(0.00)](/filings/0001493152-26-021038.md) | [(0.00)](/filings/0001493152-26-036714.md) | [(0.00)](/filings/0001493152-25-019032.md) | not reported | [(0.00)](/filings/0001493152-26-021038.md) | [(0.00)](/filings/0001493152-26-036714.md) |
| Basic EPS | $ per share | [(0.00)](/filings/0001493152-24-043492.md) | not reported | [(0.00)](/filings/0001641172-25-007701.md) | [(0.00)](/filings/0001641172-25-021604.md) | [0.01](/filings/0001493152-25-019032.md) | not reported | [(0.00)](/filings/0001493152-26-021038.md) | [(0.00)](/filings/0001493152-26-036714.md) | [(0.00)](/filings/0001493152-25-019032.md) | not reported | [(0.00)](/filings/0001493152-26-021038.md) | [(0.00)](/filings/0001493152-26-036714.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [84.7](/filings/0001493152-23-040402.md) | [41.0](/filings/0001493152-25-010854.md) | [24.3](/filings/0001493152-24-020621.md) | [408](/filings/0001493152-24-030699.md) | [149](/filings/0001493152-24-043492.md) | [48.8](/filings/0001493152-26-011555.md) | [7.6](/filings/0001641172-25-007701.md) | [8.0](/filings/0001641172-25-021604.md) | [95.2](/filings/0001493152-25-019032.md) | [65.2](/filings/0001493152-26-036714.md) | [8.7](/filings/0001493152-26-021038.md) | [22.0](/filings/0001493152-26-036714.md) |
| Current assets | $k | [254](/filings/0001493152-23-040402.md) | [76.8](/filings/0001493152-25-010854.md) | [57.1](/filings/0001493152-24-020621.md) | [440](/filings/0001493152-24-030699.md) | [216](/filings/0001493152-24-043492.md) | [81.3](/filings/0001493152-26-011555.md) | [40.1](/filings/0001641172-25-007701.md) | [19.5](/filings/0001641172-25-021604.md) | [107](/filings/0001493152-25-019032.md) | [76.8](/filings/0001493152-26-036714.md) | [20.2](/filings/0001493152-26-021038.md) | [34.1](/filings/0001493152-26-036714.md) |
| Total assets | $k | [1,250](/filings/0001493152-23-040402.md) | [1,030](/filings/0001493152-25-010854.md) | [977](/filings/0001493152-24-020621.md) | [1,305](/filings/0001493152-24-030699.md) | [1,489](/filings/0001493152-24-043492.md) | [1,390](/filings/0001493152-26-011555.md) | [1,483](/filings/0001641172-25-007701.md) | [1,448](/filings/0001641172-25-021604.md) | [1,486](/filings/0001493152-25-019032.md) | [1,407](/filings/0001493152-26-036714.md) | [1,310](/filings/0001493152-26-021038.md) | [1,321](/filings/0001493152-26-036714.md) |
| Current liabilities | $k | [1,320](/filings/0001493152-23-040402.md) | [1,503](/filings/0001493152-25-010854.md) | [2,068](/filings/0001493152-24-020621.md) | [1,990](/filings/0001493152-24-030699.md) | [1,959](/filings/0001493152-24-043492.md) | [2,212](/filings/0001493152-26-011555.md) | [2,330](/filings/0001641172-25-007701.md) | [2,450](/filings/0001641172-25-021604.md) | [2,393](/filings/0001493152-25-019032.md) | [2,984](/filings/0001493152-26-036714.md) | [3,119](/filings/0001493152-26-021038.md) | [3,375](/filings/0001493152-26-036714.md) |
| Total liabilities | $k | [4,342](/filings/0001493152-23-040402.md) | [4,591](/filings/0001493152-25-010854.md) | [5,196](/filings/0001493152-24-020621.md) | [6,058](/filings/0001493152-24-030699.md) | [4,001](/filings/0001493152-24-043492.md) | [4,235](/filings/0001493152-26-011555.md) | [4,434](/filings/0001641172-25-007701.md) | [4,620](/filings/0001641172-25-021604.md) | [4,544](/filings/0001493152-25-019032.md) | [5,113](/filings/0001493152-26-036714.md) | [5,246](/filings/0001493152-26-021038.md) | [5,380](/filings/0001493152-26-036714.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [(3,092)](/filings/0001493152-24-043492.md) | [(3,561)](/filings/0001493152-26-011555.md) | [(4,219)](/filings/0001493152-25-019032.md) | [(4,753)](/filings/0001493152-25-019032.md) | [(2,512)](/filings/0001493152-25-019032.md) | [(2,846)](/filings/0001493152-26-036714.md) | [(2,952)](/filings/0001493152-26-036714.md) | [(3,172)](/filings/0001493152-26-036714.md) | [(3,057)](/filings/0001493152-25-019032.md) | [(3,706)](/filings/0001493152-26-036714.md) | [(3,937)](/filings/0001493152-26-036714.md) | [(4,059)](/filings/0001493152-26-036714.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(314) d](/filings/0001493152-24-043492.md) | [(106) d](/filings/0001493152-25-010854.md) | [(256)](/filings/0001641172-25-007701.md) | [(288) d](/filings/0001641172-25-021604.md) | [(248) d](/filings/0001493152-25-019032.md) | [(212) d](/filings/0001493152-26-011555.md) | [13.4](/filings/0001493152-26-021038.md) | [(312) d](/filings/0001493152-26-036714.md) | [(154) d](/filings/0001493152-25-019032.md) | [(392) d](/filings/0001493152-26-011555.md) | [(419)](/filings/0001493152-26-021038.md) | [(269) d](/filings/0001493152-26-036714.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001493152-24-043492.md) | [5.8 d](/filings/0001493152-25-010854.md) | not reported | not reported | not reported | not reported | [105](/filings/0001493152-26-021038.md) | [31.5 d](/filings/0001493152-26-036714.md) | [(67.3) d](/filings/0001493152-25-019032.md) | [(0.0) d](/filings/0001493152-26-011555.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [277](/filings/0001493152-23-040402.md) | [295](/filings/0001493152-24-020621.md) | [300](/filings/0001493152-24-030699.md) | [300](/filings/0001493152-24-043492.md) | [303](/filings/0001641172-25-007701.md) | [303](/filings/0001641172-25-021604.md) | [317](/filings/0001493152-25-019032.md) | [308](/filings/0001493152-26-021038.md) | [310](/filings/0001493152-26-036714.md) | [312](/filings/0001493152-25-019032.md) | [319](/filings/0001493152-26-021038.md) | [321](/filings/0001493152-26-036714.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 324,168,980 at 2026-08-09, from the cover of the [10-Q filed 2026-08-10](/filings/0001493152-26-036714.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.